A detailed history of Venturi Wealth Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 23,898 shares of GMAB stock, worth $492,059. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,898
Previous 23,796 0.43%
Holding current value
$492,059
Previous $597,000 2.51%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$23.84 - $28.48 $2,431 - $2,904
102 Added 0.43%
23,898 $582,000
Q2 2024

Jul 19, 2024

SELL
$25.13 - $30.27 $3,367 - $4,056
-134 Reduced 0.56%
23,796 $597,000
Q1 2024

Apr 23, 2024

BUY
$26.43 - $32.77 $4,096 - $5,079
155 Added 0.65%
23,930 $715,000
Q4 2023

Jan 23, 2024

SELL
$27.94 - $35.44 $19,977 - $25,339
-715 Reduced 2.92%
23,775 $756,000
Q3 2023

Nov 02, 2023

BUY
$35.27 - $42.24 $1,798 - $2,154
51 Added 0.21%
24,490 $863,000
Q2 2023

Jul 24, 2023

BUY
$37.4 - $42.94 $1,122 - $1,288
30 Added 0.12%
24,439 $928,000
Q1 2023

May 02, 2023

BUY
$34.88 - $43.22 $74,643 - $92,490
2,140 Added 9.61%
24,409 $921,000
Q4 2022

Jan 31, 2023

SELL
$33.8 - $47.06 $166,769 - $232,194
-4,934 Reduced 18.14%
22,269 $943,000
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $13,742 - $162,893
436 Added 1.63%
27,203 $874,000
Q2 2022

Aug 12, 2022

BUY
$26.83 - $38.57 $154,192 - $221,661
5,747 Added 27.34%
26,767 $870,000
Q1 2022

May 13, 2022

BUY
$30.95 - $39.68 $6,870 - $8,808
222 Added 1.07%
21,020 $760,000
Q4 2021

Feb 08, 2022

BUY
$35.87 - $47.12 $42,864 - $56,308
1,195 Added 6.1%
20,798 $822,000
Q3 2021

Oct 19, 2021

BUY
$41.55 - $48.72 $36,273 - $42,532
873 Added 4.66%
19,603 $857,000
Q2 2021

Aug 02, 2021

BUY
$32.88 - $44.57 $27,684 - $37,527
842 Added 4.71%
18,730 $765,000
Q1 2021

Apr 22, 2021

BUY
$30.92 - $44.4 $103,520 - $148,651
3,348 Added 23.03%
17,888 $587,000
Q4 2020

Jan 28, 2021

BUY
$33.66 - $40.76 $38,372 - $46,466
1,140 Added 8.51%
14,540 $591,000
Q3 2020

Nov 03, 2020

BUY
$33.07 - $38.68 $1,884 - $2,204
57 Added 0.43%
13,400 $491,000
Q2 2020

Aug 05, 2020

BUY
$20.05 - $33.89 $258,183 - $436,401
12,877 Added 2763.3%
13,343 $452,000
Q3 2019

Oct 29, 2019

BUY
$18.0 - $21.38 $8,388 - $9,963
466 New
466 $9,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Venturi Wealth Management, LLC Portfolio

Follow Venturi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.